Publications by authors named "Leslie E Stolz"

10 Publications

  • Page 1 of 1

Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.

Authors:
Timothy J Craig H Henry Li Marc Riedl Jonathan A Bernstein William R Lumry Andrew J MacGinnitie Leslie E Stolz Joseph Biedenkapp Yung Chyung

J Allergy Clin Immunol Pract 2015 Mar-Apr;3(2):206-212.e4. Epub 2014 Oct 29.

Dyax Corp., Burlington, Mass.

View Article and Find Full Text PDF
December 2015

A phase 1 study investigating DX-2930 in healthy subjects.

Authors:
Yung Chyung Bradley Vince Ryan Iarrobino Dan Sexton Jon Kenniston Ryan Faucette Chris TenHoor Leslie E Stolz Chris Stevens Joseph Biedenkapp Burt Adelman

Ann Allergy Asthma Immunol 2014 Oct 26;113(4):460-6.e2. Epub 2014 Jun 26.

Dyax Corp, Burlington, Massachusetts.

View Article and Find Full Text PDF
October 2014

Abdominal attacks and treatment in hereditary angioedema with C1-inhibitor deficiency.

Authors:
Eitan Rubinstein Leslie E Stolz Albert L Sheffer Chris Stevens Athos Bousvaros

BMC Gastroenterol 2014 Apr 9;14:71. Epub 2014 Apr 9.

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, 300 Longwood Ave, Fegan 5th Floor, Boston, MA 02115, USA.

View Article and Find Full Text PDF
April 2014

Use of ecallantide in pediatric hereditary angioedema.

Authors:
Andrew J MacGinnitie Mark Davis-Lorton Leslie E Stolz Raffi Tachdjian

Pediatrics 2013 Aug 22;132(2):e490-7. Epub 2013 Jul 22.

Division of Immunology, Boston Children’s Hospital, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
August 2013

Outcomes after ecallantide treatment of laryngeal hereditary angioedema attacks.

Authors:
Albert L Sheffer Andrew J MacGinnitie Marilyn Campion Leslie E Stolz William E Pullman

Ann Allergy Asthma Immunol 2013 Mar 5;110(3):184-188.e2. Epub 2013 Jan 5.

Brigham and Women's Hospital, Boston, MA 02467, USA.

View Article and Find Full Text PDF
March 2013

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.

Authors:
William R Lumry Jonathan A Bernstein H Henry Li Andrew J MacGinnitie Marc Riedl Daniel F Soteres Timothy J Craig Marilyn Campion Ryan Iarrobino Leslie E Stolz William E Pullman

Allergy Asthma Proc 2013 Mar-Apr;34(2):155-61

Allergy & Asthma Specialists, Dallas, Texas, USA.

View Article and Find Full Text PDF
August 2013

Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.

Authors:
Andrew J MacGinnitie Marilyn Campion Leslie E Stolz William E Pullman

Allergy Asthma Proc 2012 Mar-Apr;33(2):178-85

Division of Immunology, Children's Hospital Boston, Massachusetts, USA.

View Article and Find Full Text PDF
August 2012

Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.

Authors:
Leslie E Stolz Albert L Sheffer

Expert Rev Clin Immunol 2012 Jan;8(1):25-32

Dyax Corp., Cambridge, MA, USA.

View Article and Find Full Text PDF
January 2012

Off-label use: an industry perspective on expanding use beyond approved indications.

Authors:
Mary E Russell Mark I Friedman Stephen R Mascioli Leslie E Stolz

J Interv Cardiol 2006 Oct;19(5):432-8

View Article and Find Full Text PDF
October 2006

Myostatin mutation associated with gross muscle hypertrophy in a child.

Authors:
Markus Schuelke Kathryn R Wagner Leslie E Stolz Christoph Hübner Thomas Riebel Wolfgang Kömen Thomas Braun James F Tobin Se-Jin Lee

N Engl J Med 2004 Jun;350(26):2682-8

Department of Neuropediatrics, Charité, University Medical Center Berlin, Berlin, Germany.

View Article and Find Full Text PDF
June 2004